Gene · 2042
Papers1,673
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,673
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lymphangiogenesis in gastric cancer: function and mechanism. | Eur J Med Res | 2023 | 37803421 | PubTator, text mining | PubMed |
| Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer. | Front Pharmacol | 2023 | 37781691 | PubTator, text mining | PubMed |
| Inhibition of EphA3 Expression in Tumour Stromal Cells Suppresses Tumour Growth and Progression. | Cancers (Basel) | 2023 | 37760615 | PubTator, text mining | PubMed |
| Study of the Removal Efficiency of Chromium Ions Using a Membrane by Electro-Kinetic Technique from Sludge. | Membranes (Basel) | 2023 | 37755228 | PubTator, text mining | PubMed |
| Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update. | Curr Oncol | 2023 | 37754534 | PubTator, text mining | PubMed |
| Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients. | Nat Commun | 2023 | 37749078 | PubTator, text mining | PubMed |
| Targeting NHE6 gene expression identifies lysosome and neurodevelopmental mechanisms in a haploid in vitro cell model. | Biol Open | 2023 | 37747131 | PubTator, text mining | PubMed |
| Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood. | Clin Epigenetics | 2023 | 37710283 | PubTator, text mining | PubMed |
| Solvation of cationic copper clusters in molecular hydrogen. | Phys Chem Chem Phys | 2023 | 37700714 | PubTator, text mining | PubMed |
| H.O.S.T.: Hemoglobin microbubble-based Oxidative stress Sensing Technology. | Sci Rep | 2023 | 37696978 | PubTator, text mining | PubMed |
| PINE-TREE enables efficient enrichment of prime-edited hPSCs. | Mol Ther Nucleic Acids | 2023 | 37680983 | PubTator, text mining | PubMed |
| A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivo. | Nat Commun | 2023 | 37673883 | PubTator, text mining | PubMed |
| Predicting the target landscape of kinase inhibitors using 3D convolutional neural networks. | PLoS Comput Biol | 2023 | 37669273 | PubTator, text mining | PubMed |
| DAB2IP suppresses invadopodia formation through destabilizing ALK by interacting with USP10 in breast cancer. | iScience | 2023 | 37664607 | PubTator, text mining | PubMed |
| A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma. | Front Oncol | 2023 | 37637064 | PubTator, text mining | PubMed |
| Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer. | Front Oncol | 2023 | 37637034 | PubTator, text mining | PubMed |
| Unlocking the Potential of Kinase Targets in Cancer: Insights from CancerOmicsNet, an AI-Driven Approach to Drug Response Prediction in Cancer. | Cancers (Basel) | 2023 | 37627077 | PubTator, text mining | PubMed |
| PTPRD mutation is a prognostic biomarker for sensitivity to ICIs treatment in advanced non-small cell lung cancer. | Aging (Albany NY) | 2023 | 37602864 | PubTator, text mining | PubMed |
| Enhancement of electrokinetic-phytoremediation by Ophiopogon japonicus: stimulation of electrokinetic on root system and improvement of polycyclic aromatic hydrocarbon degradation. | Environ Sci Pollut Res Int | 2023 | 37596476 | PubTator, text mining | PubMed |
| PINE-TREE enables highly efficient genetic modification of human cell lines. | Mol Ther Nucleic Acids | 2023 | 37588683 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2042/papers?page=7